LFST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
LifeStance Health Group Inc (LFST) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong growth prospects, positive analyst sentiment, and bullish technical indicators outweigh the negative catalysts, making it a favorable investment opportunity.
The technical indicators for LFST are bullish. The MACD histogram is positive and expanding, indicating upward momentum. The RSI is in the neutral zone, suggesting no overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near its resistance level of 6.684, with support at 6.478.
Analysts have raised price targets and maintained Buy or Overweight ratings, citing strong growth prospects, productivity improvements, and favorable reimbursement environments.
The company reported a top and bottom-line beat in Q4 2025, with adjusted EBITDA 21% above consensus.
Upcoming Q1 2026 earnings release and conference call could provide further positive momentum.
Insiders are selling, with a significant increase in selling activity (16832.26% over the last month).
Net income and EPS have significantly declined YoY in Q4 2025, indicating profitability challenges.
In Q4 2025, revenue increased by 17.43% YoY to $382.2 million, demonstrating strong growth. However, net income dropped by -264.06% YoY to $11.67 million, and EPS declined by -250.00% YoY to 0.03, reflecting profitability concerns.
Analysts are optimistic about LFST, with multiple firms raising price targets (ranging from $9 to $12) and maintaining Buy or Overweight ratings. They highlight strong growth, productivity improvements, and favorable reimbursement environments as key drivers for the stock.
